The Soluble Cytoplasmic Tail of CD45 (ct-CD45) Regulates Dendritic Cell Activation and Function via TLR4 Signaling
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26083888 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sara Gil-Cantero und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Wien, Austria. Hauptthemen laut MEDLINE: Dendritic Cells, Toll-Like Receptor 4, Signal Transduction, Leukocyte Common Antigens. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union´s Horizon 2020, European Union’s Horizon 2020 research and development program.
Abstract (Originalsprache)
The soluble cytoplasmic tail of the prototypic receptor-like protein tyrosine phosphatase (PTP) CD45 (ct-CD45) is cleaved and released into the human plasma by activated phagocytes. Released ct-CD45 was found to inhibit T cell proliferation and cytokine production via engagement of Toll-like receptor 4 (TLR4). In this study, we analyzed the impact of the ct-CD45/TLR4 pathway on the function of human monocyte-derived dendritic cells (DCs). We could demonstrate that activation of DCs by ct-CD45 upregulated the expression of certain cell surface markers (e.g., CD71 and CD86) and induced IL-10 production via TLR4. Yet, in contrast to stimulation with LPS, other typical cell surface markers and cytokines were not upregulated or induced in DCs by ct-CD45. The T cell proliferation–stimulatory capacity of DCs was not modulated by ct-CD45 treatment. However, treatment of DCs with ct-CD45 modulated the cytokine profile in co-cultured T cells. While IFN-γ production induced by DCs was strongly inhibited, the release of IL-4 was increased in T cells upon stimulation with ct-CD45-treated DCs. In contrast, ct-CD45-stimulated DCs induced IL-2 and IL-10 production in co-cultured T cells comparable to untreated DCs. In summary, we could demonstrate that ct-CD45 acts as an immunoregulatory factor for DCs via a non-canonical TLR4-dependent activation pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Wien, Austria.
ORCID-Profile: Sara Gil-Cantero, Alexander Puck, Sarojinidevi Künig, Veronica Pinnarò, Petra Waidhofer-Söllner, Johannes Stöckl
Förderung
- European Union´s Horizon 2020
- European Union’s Horizon 2020 research and development program
Zitieren
APA
Gil-Cantero, S., Puck, A., Künig, S., Pinnarò, V., Waidhofer-Söllner, P., & Stöckl, J. (2025). The Soluble Cytoplasmic Tail of CD45 (ct-CD45) Regulates Dendritic Cell Activation and Function via TLR4 Signaling. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083888
Vancouver
Gil-Cantero S, Puck A, Künig S, Pinnarò V, Waidhofer-Söllner P, Stöckl J. The Soluble Cytoplasmic Tail of CD45 (ct-CD45) Regulates Dendritic Cell Activation and Function via TLR4 Signaling. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083888
BibTeX
@article{GilCantero2025,
author = {Gil-Cantero, Sara and Puck, Alexander and Künig, Sarojinidevi and Pinnarò, Veronica and Waidhofer-Söllner, Petra and Stöckl, Johannes},
title = {The Soluble Cytoplasmic Tail of CD45 (ct-CD45) Regulates Dendritic Cell Activation and Function via TLR4 Signaling},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26083888}
}
EUVIMED